Navigation Links
PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
Date:6/23/2011

SAN CARLOS, Calif., June 23, 2011 /PRNewswire/ -- PharmacoFore, Inc., a privately held biopharmaceutical company developing next-generation abuse-resistant prescription drugs, today announced positive results from a Phase I human proof-of-concept (hPOC) study of its hydromorphone (HM) Bio-Activated Molecular Delivery™ (Bio-MD™) product candidate, PF329.  Greg Sturmer, VP, Finance and CFO, will present at the 2011 BIO Business Forum during the annual BIO International Convention at the Walter E. Washington Convention Center in Washington, D.C.  Mr. Sturmer's presentation will be given on Thursday, June 30, 2011, at 10:00 a.m. EDT in the Georgetown Room.  The presentation will include an overview of the company's Bio-MD™ and Multi-Pill Abuse-Resistance™ (MPAR™) technologies and pipeline.

The Bio-MD™ technology is designed to release clinically effective opioid drug only when exposed to the correct physiologic conditions (i.e., when orally ingested). The result is activation and controlled release of an opioid drug in the gastrointestinal tract, which is then absorbed normally into the patient's blood stream.  This approach achieves two important goals: (i) greatly reducing the opportunities for abuse of opioid drugs, and (ii) maintaining, unaltered, the opioid's potent analgesic effects in a safe manner.

The Phase 1 hPOC study demonstrated that PF329 is safe and releases HM in a dose-proportional manner and that the process of delivery is efficient.  Time to maximal plasma concentration of HM following administration of PF329 is approximately two hours, slower than immediate release HM and more rapid than the published data for the commercial, once-per-day HM product, Exalgo®.  By delivering PF329 in solution in this study, PharmacoFore demonstrated that the extended release profile is intrinsic to the molecule; that is, the Bio-MD technology does not involve the reformulati
'/>"/>

SOURCE PharmacoFore, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FluoroPharma Announces $1.6M Capital Raise
2. Akorn, Inc. Announces Second Quarter 2011 Earnings Release and Conference Call Information
3. Merriman Capital Announces Sponsorship of Radient Pharmaceuticals Corporation on OTCQX
4. ULURU Inc. Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor
5. Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRST® - Progesterone VGS Compounding Kit
6. MacroGenics Announces Presentation of Protege Phase 3 Clinical Data at ADA in San Diego on June 28
7. Watson Announces Expansion of Salt Lake City, Utah Pharmaceutical R&D and Manufacturing Facility
8. Lupin Announces Launch of Generic Levaquin® Tablets
9. Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation
10. OncoSec Medical Announces the Appointment of Dr. Anthony E. Maida, III, to Its Board of Directors
11. Oxford BioMedica Announces Ocular Programme Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... July 25, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ... corporate update and report second quarter 2014 financial results ... August 1, 2014. That same day, Arena will host ... Time (5:30 a.m. Pacific Time). The ... domestic callers and 914.495.8552 for international callers. Please specify ...
(Date:7/24/2014)... , July 24, 2014  PTC Therapeutics, Inc. ... Company will host a webcast conference call to report ... update on the company,s business and outlook on Thursday, ... opening of the market. The call ... (973) 935-8152 (international) five minutes prior to the start ...
(Date:7/24/2014)... 24, 2014  Uroplasty, Inc. (NASDAQ: UPI ... and markets innovative proprietary products to treat voiding ... 2015 first quarter ended June 30, 2014.  ... Neuromodulation System grew 19% to $4.1 million, as ... of the prior year.  Total revenue for the ...
Breaking Medicine Technology:Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11
... Australia, March 12, 2007: Progen Industries Limited,(ASX: PGL; NASDAQ: ... liver cancer data has been accepted for late breaking ... the Liver,(EASL). Progen will also be presenting the results ... Cancer Research (AACR),Annual Meeting 2007. , ,In expectation ...
... - Tyrima Demonstrates Good Safety Profile and Excellent,Pharmacokinetic ... 2007 /PRNewswire/ --,CeNeRx BioPharma, Inc., a clinical stage ... the central,nervous system, today announced top-line results from ... candidate for the treatment,of depression and anxiety. In ...
Cached Medicine Technology:PI-88 Data to be Presented at Key International Conferences 2PI-88 Data to be Presented at Key International Conferences 3CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3
(Date:7/25/2014)... 2014 Reproductive Science Center (RSC) of ... Kerri Luzzo, Lead Physician at RSC Rhode Island, received ... accomplishments in fertility care and community outreach issued by ... Annual PBN Awards ceremony held July 24th at Salve ... most highly regarded, emerging leaders in their field were ...
(Date:7/25/2014)... 25, 2014 Florida Hospital and MOSI officially ... organizations for years to come and make a difference in ... $2 million dollar check to provide the support needed to ... enable MOSI to transform the IMAX Dome Theatre from film ... the only IMAX Dome Theatre in the state of Florida, ...
(Date:7/25/2014)... -- The human brain can preserve oxygen to protect ... finds. Although dehydration significantly reduces blood flow ... the brain compensates by increasing the amount of oxygen ... helped us understand a lot more about how the ... study first author Steven Trangmar, a researcher at Brunel ...
(Date:7/25/2014)... San Diego, CA (PRWEB) July 25, 2014 ... regarding all the latest information from the FDA on ... on July 21, that one lot of Ibuprofen and one ... recalled due to mislabeled packaging. Oxcarbazepine is used ... with epilepsy. , The reason for the recall ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 A new study ... revealed that 39 percent of all children in the survey ... , The survey looked at 2,505 children during the years of ... four years of age. The final result was that about ... care. Many of these children were from lower-income families and were ...
Breaking Medicine News(10 mins):Health News:Dr. Kerri Luzzo of the Reproductive Science Center of Providence Receives “40 Under Forty Award" for Outstanding Professional Accomplishments and Community Outreach 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 3Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 4Health News:Human Brain Has Coping Mechanism for Dehydration 2Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:North York Dental Provides Services to Toronto Children in Light of Growing Demand 2Health News:North York Dental Provides Services to Toronto Children in Light of Growing Demand 3
... Now all those doting dads will be given some tips ... e-mails . ,The British government is hoping that ... to support parents will appeal to fathers, as it makes ... electronic organisers and instant messaging. ,Under the ...
... effectively pulls the tongue closer to the jawbone and opens ... and sleep apnea, suggest early results of a study . ... the resulting sound due to obstructed air movement during breathing ... unpleasant. It can sometimes be frustrating for patients and their ...
... Beckham are among celebrities whose sketches have been drawn with ... Rich Clarke, who created the artworks, says that he was ... killer, working for the police and analysing blood at crime ... making these artworks by FX Channel to coincide with the ...
... conventionally grown products. A US study reports that organic ... risk of heart disease and stroke. ... produce found almost double the level of flavonoids - ... quercetin and kaempferol aglycones than their conventionally grown counterparts. ...
... invasive method of treating cancer and they hope ... cancer soon . ,The development of ... result of the efforts of Virginia Techbiomedical engineer ... professor Boris Rubinsky. ,For decades, ...
... Fermin running of the bulls festival on Friday, with more ... their chances in the bull run . ,The ... copious amounts of drinking -- in Pamplona in northeastern Spain. ... the "encierro", when bulls are released onto the streets each ...
Cached Medicine News:Health News:New Device to Treat Snoring and Sleep Apnea 2Health News:Organically Grown Food More Healthier 2Health News:Scientists Destroy Cancer Cells Using Electric Pulses 2
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
Inquire...
... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
... Hamilton is precision, ergonomics, and ... hand fatigue with soft non-slip, contoured ... with smooth, light plunger spring action ... and sterilization without the need for ...
Medicine Products: